Method for the treatment of T cell mediated conditions by depletion of icospositive cells in vivo

Details for Australian Patent Application No. 2005235718 (hide)

Owner Bundesrepublik Deutschland Letztvertreten durch das Robert-Koch-Institut vertreten durch seinen Prasidenten

Inventors Kroczek, Richard

Agent Watermark

Pub. Number AU-B-2005235718

PCT Pub. Number WO2005/103086

Priority 60/581,479 21.06.04 US; 04009659.6 23.04.04 EP

Filing date 22 April 2005

Wipo publication date 3 November 2005

Acceptance publication date 22 September 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

Event Publications

16 November 2006 PCT application entered the National Phase

  PCT publication WO2005/103086 Priority application(s): WO2005/103086

22 September 2011 Application Accepted

  Published as AU-B-2005235718

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005235721-Polyethylene and catalyst composition for its preparation

2005235711-Hydrotreating catalyst containing a group V metal